Cano Health Stock (CANO): $12 Price Target From Citi

By Amit Chowdhry ● Jan 14, 2022
  • The shares of Cano Health Inc (NYSE: CANO) have received a price target of $12 from Citi. These are the details.

The shares of Cano Health Inc (NYSE: CANO) have received a price target of $12 from Citi. And Citi analyst Jason Cassorla assumed coverage of Cano Health with a “Buy” while reducing the price target from $20.

Cassorla had assumed coverage of the healthcare services space with a cautious but generally optimistic view. And Cassorla said that while the backdrop remains fluid, the playing field has shifted as we enter this year with greater vaccine uptake and a relatively milder variant compared to last year.

Cassorla noted that amid this backdrop, he sees 3 major themes/debates driving the sector, including COVID-19 rollover and normalization of underlying core trends, inflationary cost pressures and offsets, and the reversion of focus back to structural shifts underpinning the healthcare industry.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.